<DOC>
	<DOCNO>NCT01402583</DOCNO>
	<brief_summary>Menopause represent critical period woman 's life hormonal change fail ovarian function determine relevant modification reproductive function also many condition organ apparently scarcely link hormone . The PI 's centre among main goal treatment chronic liver disease ; last year , increase interest gender-related issue grow . Goal study verify impact menopause response antiviral therapy CHC determine severe fibrosis comparison age-matched men . To achieve goal database PEG IFN/Ribavirin patient treat GI Unit University Modena Reggio Emilia last 7 year set . Demographic , clinical biochemical data well data regard reproductive history , time , type , length estrogen deprivation hormone-replacement therapy collect .</brief_summary>
	<brief_title>Menopause Critical Factor Determining Failure Antiviral Therapy Women With Chronic Hepatitis C</brief_title>
	<detailed_description>The study design retrospective epidemiological cohort study . Overall , group 442 woman ( 168 still fertile age ; 274 menopausal ) HCV-positive CAH underwent PEG IFN treatment last 5 year evaluate . For comparison , group 548 HCV-positive male CAH evaluate . Liver biopsies undergo standard antiviral therapy score fibrosis , inflammation steatosis . In woman presence , type timing menopause , associate hormonal/metabolic feature serum interleukin-6 ( IL-6 ) hepatic tumor necrosis factor-α ( TNF-α ) level evaluate . The primary endpoint evaluation SVR female ( fertile menopausal age ) male .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>All woman treat HCV chronic hepatitis , Unit Gastroenterology , University Modena Reggio Emilia , last 7 year . Control group cohort match age ( ratio 1:1 ) select group 558 men chronic HCV treat period No exclusion criterion aret predefined study include patient treat chronic HCV hepatitis ; exclusion make upstream constitution cohort .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Gender</keyword>
	<keyword>Menopause</keyword>
	<keyword>Sustained viral response</keyword>
	<keyword>Cytokines</keyword>
</DOC>